Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
PAAB exemption for a pharmacy communication?
-
I'm looking into the PAAB code regarding what is/isn't PAAB exempt (s1.5), and I would just like to ask for some more clarification.
s1.5.d states that contextual use of a healthcare product name can only be used in a context wherein it is not connected to therapeutic or promotional claims. s1.5.d then also gives examples of where this is permitted. However, is that an exhaustive list of examples?
E.g., if I wanted to create a short piece just announcing the availability of a specific drug and nothing else, something like "X is back in stock", would that be PAAB exempt per s1.5.d? It seems similar to s1.5.d.iii, but it isn't the same.
As a follow-up question, would the indication statement count as attaching the drug name to a therapeutic claim, thereby requiring PAAB approval?
-
I'm looking into the PAAB code regarding what is/isn't PAAB exempt (s1.5), and I would just like to ask for some more clarification.
s1.5.d states that contextual use of a healthcare product name can only be used in a context wherein it is not connected to therapeutic or promotional claims. s1.5.d then also gives examples of where this is permitted. However, is that an exhaustive list of examples?
E.g., if I wanted to create a short piece just announcing the availability of a specific drug and nothing else, something like "X is back in stock", would that be PAAB exempt per s1.5.d? It seems similar to s1.5.d.iii, but it isn't the same.
As a follow-up question, would the indication statement count as attaching the drug name to a therapeutic claim, thereby requiring PAAB approval?
Hey @stanley, sorry for the late response, this one must have slipped through the cracks.
S.1.5 is not considered to be an exhaustive list. The copy “X is back in stock” would be viewed as a commercial availability message. If it was not linked to any other messaging, it could be considered exempt.
You are correct, the addition of the indication statement would create a link to the therapeutic use and prompt at least lowest level fair balance and PAAB review.
